FOI release

Request for Status Update – Marketing Authorisation Application for DCVax-L (Northwest Biothera...

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2025/00535

Received 2 June 2025

Published 5 August 2025

Request

Requested Information: 1. What is the current status of the MAA submitted by Northwest Biotherapeutics for DCVax-L? 2. Has the application been referred to the Committee on Human Medicines (CHM) for further review or advice? 3. Were any clock stops issued during the review, and if so, what were their durations? 4. Has the MHRA issued any Major Objections, requests for withdrawal, or rejection notices to the applicant? 5. Can you confirm whether a final decision is pending, deferred, or expected within a certain timeframe?

Response

see attached

Documents

• FOI2025_00535 redacted for publication.pdf (113.7 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.